Cargando…
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial
BACKGROUND: The use of electroconvulsive therapy (ECT) is limited by concerns about its cognitive adverse effects. Preliminary evidence suggests that administering the glutamate antagonist ketamine with ECT might alleviate cognitive adverse effects and accelerate symptomatic improvement; we tested t...
Autores principales: | Anderson, Ian M, Blamire, Andrew, Branton, Tim, Clark, Ross, Downey, Darragh, Dunn, Graham, Easton, Andrew, Elliott, Rebecca, Elwell, Clare, Hayden, Katherine, Holland, Fiona, Karim, Salman, Loo, Colleen, Lowe, Jo, Nair, Rajesh, Oakley, Timothy, Prakash, Antony, Sharma, Parveen K, Williams, Stephen R, McAllister-Williams, R Hamish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406618/ https://www.ncbi.nlm.nih.gov/pubmed/28359862 http://dx.doi.org/10.1016/S2215-0366(17)30077-9 |
Ejemplares similares
-
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)
por: Trevithick, Liam, et al.
Publicado: (2015) -
Frontal haemodynamic responses in depression and the effect of
electroconvulsive therapy
por: Downey, Darragh, et al.
Publicado: (2019) -
Electroconvulsive therapy (ECT) with ketamine induction for catatonia in an HIV positive patient
por: Nel, Yvette, et al.
Publicado: (2023) -
Cognitive function after electroconvulsive therapy for depression: relationship to clinical response
por: Anderson, Ian M., et al.
Publicado: (2021) -
A review of ketamine’s role in ECT and non-ECT settings
por: Jankauskas, Vytautas, et al.
Publicado: (2018)